Manufacturer
Travere Therapeutics
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 2
Travere Therapeutics is a pharmaceutical manufacturer based in United States. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Travere Therapeutics, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Travere Therapeutics products through licensed channels, with the documents your regulator needs.
Cardiology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Filspari 200 mg tabletOral | Sparsentan | US FDA | Available on request |
| Filspari 400 mg tabletOral | Sparsentan | US FDA | Available on request |
Gastroenterology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Chenodal 250 mg tabletOral | Chenodiol | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Travere Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.